Analystreport

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) had its price target raised by analysts at HC Wainwright to $9.00. They now have a "positive" rating on the stock.

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com